Amino acid surrogates for peptidic constructs

Drug – bio-affecting and body treating compositions – Solid synthetic organic polymer as designated organic active... – Ion exchange resin

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C424S001690, C514S043000, C530S332000, C530S333000

Reexamination Certificate

active

07964181

ABSTRACT:
Ring-constrained amino acid surrogates of formula I:where R1, R2, R3, R4, R5, R6a, R6b, R7, and y are as defined in the specification, methods for synthesizing ring-constrained amino acid surrogates of formula I, methods of use of ring-constrained amino acid surrogates of formula I, including use in linear or cyclic compounds which include a plurality of amino acid residues and one or more ring-constrained amino acid surrogates of formula I and linear or cyclic compounds which include a plurality of amino acid residues and one or more ring-constrained amino acid surrogates of formula I.

REFERENCES:
patent: 4251438 (1981-02-01), Moon
patent: 4341698 (1982-07-01), Carr et al.
patent: 5559232 (1996-09-01), Ackermann et al.
patent: 5929237 (1999-07-01), Kahn
patent: 6013458 (2000-01-01), Kahn et al.
patent: 6184223 (2001-02-01), Kahn et al.
patent: 6413963 (2002-07-01), Kahn et al.
patent: 6462046 (2002-10-01), Lou et al.
patent: 6943157 (2005-09-01), Nagula et al.
patent: 7008941 (2006-03-01), Urban et al.
patent: 2002/0111348 (2002-08-01), Reichard et al.
patent: 2003/0019049 (2003-01-01), Kravtchenko et al.
patent: 2004/0224957 (2004-11-01), Sharma
patent: 2006/0217532 (2006-09-01), Miao et al.
patent: 2006/0234923 (2006-10-01), Zumbrunn et al.
patent: 3022401 (1981-01-01), None
patent: 2717484 (1995-09-01), None
patent: WO 92/21361 (1992-12-01), None
patent: WO 99/43662 (1999-09-01), None
patent: WO 99/48913 (1999-09-01), None
patent: WO 99/55684 (1999-11-01), None
patent: WO-02/85925 (2002-10-01), None
patent: WO 02/085925 (2002-10-01), None
patent: WO 2007/115175 (2007-10-01), None
patent: WO 2007/115182 (2007-10-01), None
Tong, 1998, Bioorganic and Medicinal Chemistry Letters, 8, 1679-1682.
Su, 2003, Bioorganic and Medicinal Chemistry Letters, 13, 1679-1682.
Mohammad, 1998, Tetrahedron Letters, 39, 8213-8216.
Kolter, 1995, Liebigs Ann., 625-629.
DiMaio, 1989, J. Chem. Soc. Perkin Trans, 1687-1689.
Rubsam, 2000, Tetrahedron, 56, 8481-8487.
Goff, 1996, Tetrahedron Letters, 37, 6247-6250.
Shigematsu, 1988, Tetrahedron Letters, 29, 5147-5150.
Masuzawa, et al., The Reaction of C-Substituted Ethylenediamine with the Ester of Alpha-Halo Acid, vol. 38, No. 12, 2078-2081 (1965).
PCT International Preliminary Report on Patentability in PCT/US2007/065632 dated Mar. 3, 2009.
S.M. Hecht, Bioorganic Chemistry: Peptides and Proteins, Oxford University Press, 1998, 395-419.
Rubsam, F., et al., Synthesis of chiral piperazinones as versatile scaffolds for peptidomimetics, Tetrahedron, 2000, 56(43) 8481-8487.
Kolter, T., et al., Synthesis of substituted chiral piperazinones as building blocks for peptidomimetics, Liebigs Annalen, 1995, 4, 625-629.
DiMaio, John, et al., Synthesis of Chiral Piperazin-2-ones as Model Peptidomimetics, J. Chem. Soc., 1989, 1687-1689.
Dutta, A.S., Potent Cyclic Monomeric and Dimeric Peptide, etc., Journal of Peptide Science, 2000, vol. 6, pp. 321-341, especially pp. 323-325, Table 1, compounds 47-58.
de Visser, Solid-phase synthesis of polymyxin B1 and analogues via, etc. P.C.J. Peptide Res., 2003, vol. 61, pp. 298-306, especially p. 303, Table 1, compounds 27-28.
Masuzawa et al., The Reaction of C-Substituted Ethylenediamine with the Ester of Alpha-Halo Acid, Apr. 1965, vol. 38, No. 12, pp. 2078-2081.
Shreder, K., et al, “Synthesis of a Constrained Enkephalin Analog to Illustrate a Novel Route to the Piperazinone Ring Structure”, Tetrahedron Letters, Elsevier, Amsterdam vol. 39, No. 3-4, Jan. 15, 1998, pp. 221-224, ISSN: 0040-4039.
Communication from European Patent Office in European Patent Application 07759821.7, dated Oct. 2, 2009, and including Supplementary European Search Report and European Search Opinion.
Goff D.A., et al: Tetrahedron Letters, Elsevier, Amsterdam, NL Lnkd.—DOI:10.1016/0040-4039(96)01382-2, vol. 37, No. 35, Aug. 26, 1996, pp. 6247-6250.
Shigematsu, N., et al.: “Structure and Synthesis of FR-900490 A New Immunomodulating Peptide Isolated From A Fungus” Tetrahedron Letters, vol. 29, No. 40, 1988, pp. 5147-5150.
Communication pursuant to Article 94(3) EPC in European Application No. 07759821.7, Jun. 8, 2010.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Amino acid surrogates for peptidic constructs does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Amino acid surrogates for peptidic constructs, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Amino acid surrogates for peptidic constructs will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2682893

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.